29376112de Alarcon PA, Matthay KK, London WB, Naranjo A, Tenney SC, Panzer JA, Hogarty MD, Park JR, Maris JM, Cohn SLThe Lancet. Child & adolescent healthAnti-Inflammatory Agents; Immunoglobulins, Intravenous; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; PrednisoneAntineoplastic Combined Chemotherapy Protocols; Ataxia; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Male; Neurologic Examination; Severity of Illness IndexIntravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health. 2018 01; 2(1):25-34.Lancet Child Adolesc Health2017-11-03T00:00:002017Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD001259Disorders25370.969641AtaxiaD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD000893Chemicals & Drugs1513390.803721Anti-Inflammatory AgentsD002648Living Beings93969130.440068ChildD002675Living Beings65236080.594978Child, PreschoolAuthorship 120751100.6416640.6416641authors10.2516has subject areaD009460Procedures701180.953159Neurologic ExaminationD007223Living Beings60430360.613076InfantD005260Physiology1992444050.191184FemaleD011241Chemicals & Drugs1132550.929584PrednisoneD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD053578Disorders240.990551Opsoclonus-Myoclonus SyndromeD012720Concepts & Ideas54117960.649256Severity of Illness IndexD016756Chemicals & Drugs51660.946165Immunoglobulins, IntravenousD009447Disorders993740.745685NeuroblastomaD018572Concepts & Ideas25812030.792724Disease-Free SurvivalPediatricsUniversity of ChicagoSusan L.CohnxGFmA69EOfnamXNnYUHhvWD+6g==Susan L. Cohn41.78927490000000-87.601250000000001250Cohn, Susan L.Professortrue1ProfessorProfessor